BA
SGMO

Bridgewater Advisors’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Bridgewater Advisors’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-13,780
Closed -$191K – 95
2013
Q4 		$191K Buy
+13,780
New +$159K 0.2% 77

Other funds holding SGMO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Bridgewater Advisors's SGMO Position: Q1 2014 in Review

Bridgewater Advisors sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2014, closing a stake of 13,780 shares — an estimated $191K sold.

Bridgewater Advisors first reported a position in SGMO in Q4 2013 and held it in 1 quarter. The position peaked at $191K in Q4 2013. 145 funds tracked by Wall St. Rank hold SGMO as of Q1 2014.

  • Bridgewater Advisors reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2014 after selling out during the quarter.
  • Bridgewater Advisors sold 13,780 SANGAMO THERAPEUTICS INC shares in Q1 2014, an estimated $191K.
  • Bridgewater Advisors first reported a position in SANGAMO THERAPEUTICS INC in Q4 2013 and held it in 1 quarter.
  • Bridgewater Advisors's SANGAMO THERAPEUTICS INC position peaked at $191K in Q4 2013.
  • 145 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2014.

Based on Bridgewater Advisors's 13F filing for Q1 2014, filed 1 May 2014.